ABSTRACT
Background More older adults enrolled in Medicare Advantage (MA) are entering nursing homes (NHs), and MA concentration could affect vaccination rates through shifts in resident characteristics and/or payer related influences on preventive services use. We investigated whether rates of influenza vaccination and refusal differ across NHs with varying concentrations of MA-enrolled residents.
Methods We analyzed 2014-2015 Medicare enrollment data and Minimum Data Set clinical assessments linked to NH-level characteristics, star ratings, and county-level MA penetration rates. The independent variable was the percentage of residents enrolled in MA at admission and categorized into three groups. We examined three NH-level outcomes: percentage of residents assessed and appropriately provided the influenza vaccine, receiving influenza vaccine, and refusing influenza vaccine.
Results There were 936,513 long-stay residents in 12,384 NHs. Categories for the prevalence of MA enrollment in NHs were low (0% to 3.3%; n=4131 NHs), moderate (3.4% to 18.6%; n=4127 NHs) and high (>18.6%; n=4126 NHs). Adjusting for covariates, influenza vaccination rates among long-stay residents were higher in NHs with moderate (1.7%, P<0.0001), or high (3.1%, P<0.0001) MA versus the lowest prevalence of MA. Influenza vaccine refusal was lower in NHs with moderate (−3.1%, P<0.0001), or high (−4.6% P<0.0001) MA compared with NHs with the lowest prevalence of MA. Among 753,616 short-stay residents in 12,205 NHs, there was no association between MA concentration and influenza vaccination receipt but vaccine refusal was greater in NHs with higher MA prevalence (high or moderate vs. low MA: 5.2%, P<0.0001).
Conclusion The relationship between MA concentration and influenza vaccination measures varied among post-acute and long-term NH residents. As MA takes a larger role in the Medicare program, and more MA beneficiaries enter NHs, there is need to consider how managed care can be leveraged to improve the delivery of preventive services such as influenza vaccinations in NH settings.
Competing Interest Statement
EB, ARZ, BHB, and PM declare no conflicts of interest. RVA and AC are employed by Sanofi Pasteur. SG reports grants and personal fees from Seqirus, Sanofi; and consulting or speaker fees from Sanofi, Merck, Longeveron, and the Gerontological Society of America for research related to vaccines or nursing home care quality.
Funding Statement
Sanofi Pasteur provided a research grant to Brown University to support this study as part of a larger project aiming to estimate the burden of infections in long-term care. Brown University retained the right to publish and publicly present all results. Sanofi Pasteur was not involved in establishing the scope of the study, creating the initial protocol, designing the study, or performing analysis, but was involved in suggesting edits to the final study protocol and reviewing the final manuscript. Incorporation of any edits suggested by Sanofi Pasteur was not compulsory. Dr. Zullo is also supported, in part, by grants from the National Institute on Aging (R21AG061632 and R01AG065722) and National Institute of General Medical Sciences (U54GM115677).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Brown University Institutional Review Board approved this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding: This work was supported by a grant to Brown University from Sanofi Pasteur. Dr. Zullo is also supported, in part, by grants from the National Institute on Aging (R21AG061632 and R01AG065722) and National Institute of General Medical Sciences (U54GM115677).
Conflicts of Interest: Potential conflicts of interest. PM, EB, ARZ, BHB, and MRH declare no conflicts of interest. RVA and AC are employed by Sanofi Pasteur. SG reports grants and personal fees from Seqirus, Sanofi; and consulting or speaker fees from Sanofi, Merck, Longeveron, and the Gerontological Society of America for research related to vaccines or nursing home care quality.
Data Availability
The data used in this study are not available for sharing due to restrictions of data use agreements with the U.S. Centers for Medicare and Medicaid Services.
